Literature DB >> 9278185

Cortical dopamine in schizophrenia: strategies for postmortem studies.

D A Lewis1, M Akil.   

Abstract

Many of the symptoms of schizophrenia appear to involve dysfunction of the cognitive processes mediated by the neural circuitry of the cerebral cortex. The application of modern neuroscience techniques to the study of postmortem human brain specimens provides a powerful approach for exploring the manner in which cortical circuitry may be disrupted in schizophrenia. In this paper, we describe a strategy for the conduct of postmortem investigations of schizophrenia that involves (1) the use of a nonhuman primate model to guide the design and interpretation of studies in humans; (2) the detailed characterization of the normal organization of neural systems in the human cerebral cortex, and the range of inter-individual variations in that organization; and (3) the testing of specific hypotheses about the disruption of that organization in schizophrenia. The application of this strategy, and its value in overcoming some of the potential pitfalls of postmortem studies, is demonstrated in a series of investigations designed to test the hypothesis that dopamine neurotransmission is impaired in the entorhinal cortex in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278185     DOI: 10.1016/s0022-3956(96)00057-x

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  8 in total

1.  Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats.

Authors:  James D Belluzzi; Alex G Lee; Heather S Oliff; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

Review 2.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 3.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

4.  Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens.

Authors:  D B Carr; P O'Donnell; J P Card; S R Sesack
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

5.  AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs.

Authors:  J A O'Connor; E C Muly; S E Arnold; S E Hemby
Journal:  Schizophr Res       Date:  2006-12-01       Impact factor: 4.939

6.  Evidence for intact local connectivity but disrupted regional function in the occipital lobe in children and adolescents with schizophrenia.

Authors:  Tonya White; Steen Moeller; Marcus Schmidt; Jose V Pardo; Cheryl Olman
Journal:  Hum Brain Mapp       Date:  2011-06-14       Impact factor: 5.038

Review 7.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.

Authors:  Matcheri S Keshavan; Urvakhsh Meherwan Mehta; Jaya L Padmanabhan; Jai L Shah
Journal:  Dev Psychopathol       Date:  2015-05

Review 8.  Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.

Authors:  I Bonoldi; O D Howes
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.